Labmanager Logo
Scanning electron microscope image of the crystal structure of cubic zirconium, showing two clearly defined cubes surrounded by some spherical shapes and a web-like structure, all in black and white

Aaron Celestian

Scientists Discover First-Ever Mineral-Based Treatment for Widespread Disease

Using the structure of cubic zirconium silicate, the innovative treatment opens doors to future mineral-based treatments

| 2 min read
Share this Article
Register for free to listen to this article
Listen with Speechify
0:00
2:00

In a groundbreaking discovery, scientists at the Natural History Museum of Los Angeles County and pharmaceutical firm AstraZeneca have published the first-ever mineral-based treatment for a widespread disease. Reported in the journal PLOS One, the study by mineralogist Dr. Aaron Celestian, Curator of Mineral Sciences at NHM, and pharmaceutical chemist Dr. Jason Lively opens the door to more advanced mineral-based treatments in the future.

The paper describes how crystals have been used as a new treatment for hyperkalemia, a disease that affects roughly 350 million people across the planet. Hyperkalemia strikes when a person has too much potassium in their blood and cannot regulate potassium levels. It can result in cardiac arrest in acute cases or cause kidney and liver dysfunction or failure in persistent cases that last decades. 

Lab manager academy logo

Get training in Lab Crisis Preparation and earn CEUs.

One of over 25 IACET-accredited courses in the Academy.

Certification logo

Lab Crisis Preparation course

“For people suffering from hyperkalemia, the biological processes that regulate potassium in the body are not working optimally, so they have to constantly manage their condition through medications that have potentially harmful side effects and dietary restrictions,” says Celestian. 

The new treatment lets patients flush the excess potassium through ion transfer. “The crystals find the potassium, absorb it, and then excess gets filtered out of the body through the kidneys,” says Celestian.

The researchers used the crystal structure of cubic zirconium silicate to develop a treatment without harmful biological interaction—and associated negative side effects.  This is a new way to alleviate deleterious effects on patients that other treatments have.

“It’s like material engineering using minerals as a template,” says Celestian. “Nature’s already grown incredible tools for treating illnesses, and we’re only just beginning to harness those tools.”

Besides having significantly less biological interaction, mineral-based therapies might offer the chance for more durable treatments. Using the structure of crystals means that similar treatments could potentially overcome mutations that make things like viruses so difficult to treat effectively. 

Interested in Biopharma News?

Subscribe to our free Biopharma Tools and Techniques newsletter.

“Minerals probably don’t care about how a virus mutates, as long as it has those building block proteins that the mineral likes to interact with,” says Celestian.

- This press release was originally published on the Natural History Museum of Los Angeles County website

Loading Next Article...
Loading Next Article...

CURRENT ISSUE - October 2024

Lab Rats to Lab Tech: The Evolution of Research Models

Ethical and innovative scientific alternatives to animal-based R&D

Lab Manager October 2024 Cover Image
Lab Manager Biopharma eNewsletter

Stay Connected with Biopharma News

Click below to subscribe to Biopharma Tools and Techniques eNewsletter!

Subscribe Today